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Case Report
Abstract
Juvenile fibroadenoma comprises about 4% of the total fibroadenomas. The incidence of giant juvenile fibroadenomas is merely
0.5% of all the fibroadenomas. Bilateral giant juvenile fibroadenomas are extremely rare. We are presenting a case of giant ju-
venile fibroadenomas in an 11-year-old pre-pubertal girl. The diagnosis was made on fine-needle aspiration cytology which was
confirmed on histopathology. As these tumors are mostly benign, breast-conserving surgery is done so that patient can lead a
normal life without psychological trauma.
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Introduction
Fibroadenoma of the breast is a benign tumor affecting fe-
males usually before the age of 30 (commonly between 10-18
years).1 If fibroadenoma occupies a major fraction of the
breast and weighs more than 500 gram, it is named as "giant
fibroadenoma breast". In 1829, Sir Astley Coop described
fibroadenomata as a tumor belonging to a group called
"chronic mammary tumors." Subsequently, Brodie classified
fibroadenoma as "sero-cystic tumors of the female breast". In
1934, Oliver described breast mass as benign growth and
named it as fibroadenomata.2 Fibroadenomas and abscess are
common in breasts of children. Juvenile fibroadenoma is a
rare clinical entity and forms 4 % of the total fibroadenomas,
and giant juvenile fibroadenoma constitutes only 0.5 % of all
fibroadenomas.3 Bilateral giant juvenile fibroadenomas are
extremely rare in prepubertal girls.4
Case Report
An 11-year-old pre-menarche girl presented with rapidly
enlarging right breast lump for three months. There was
history of mild pain in the breasts. There was no history of
trauma, nipple discharge, fever, anorexia, or weight loss. On
local examination there was a slightly tender, huge,
well-circumscribed mass in the right breast which was firm in
consistency. The overlying skin was tense and shiny with
prominent superficial veins without ulceration. There was no
discharge from the nipple. The right breast lump measured 16
× 13 cm. The lumps were not fixed to underlying structures.
Axillary lymphadenopathy was absent. Routine blood ex-
aminations were within normal limits. Chest-X ray was
normal. Ultrasonography of breast showed heterogeneous
parenchymal pattern suggestive of fibroadenoma. Fi-
ne-needle aspiration cytology (FNAC) of breast lumps
showed cellular smears comprising of many branching mon-
olayer sheets along with myoepithelial cells (Figure 1). Based
on the cytological findings, diagnosis of benign proliferative
lesion without atypia suggestive of fibroadenomas was made.
FIG. 1: Cytology slide showing at high power (40X); myoepithelial
cells can be easily appreciated.
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Total excision of right breast lump was done and the normal
breast tissue, nipple, and areola were preserved. The resected
specimen was sent for histopathological study in the depart-
ment of pathology. The right-sided excised lump measured 16
× 13 × 7.5 cm and it weighed 600 gm. External surface was
bosselated, and the lumps were well circumscribed and en-
capsulated.
Hematoxylin- and eosin-stained sections revealed
well-encapsulated tumors with hyperplasia of both epithelial
and stromal components. Epithelial component showed tub-
ular or tufted pattern of epithelial hyperplasia with charac-
teristic tufts of cells protruding into the lumina. The glands
were lined by bilayered epithelium at places showing strati-
fication. Most of the areas in both the tumors showed a peri-
canalicular pattern of fibroadenoma. There was no leaf-like
growth pattern and cytological atypia despite of stromal cel-
lularity. The final histopathological diagnosis of giant juvenile
fibroadenomas of right breast was reported (Figure 2). The
patient is on regular follow up and doing well at nine months
follow up.
FIG. 2: Histopathology of tumor showing at 10x; ductal epithelium is
clearly appreciated.
Discussion
Juvenile or cellular fibroadenoma is an infrequent histological
variation of fibroadenoma that undergoes a rapid growth. A
fibroadenoma over 5-10 cm in diameter and weighing more
than 500 gram is termed a “giant fibroadenoma” (as in our
case). Although most giant fibroadenomas are of the cellular
subtype, not all cellular fibroadenomas are giant. They usu-
ally exhibit rapid growth and occupy most of breast. It is
commonly seen in young and black patients. Juvenile fi-
broadenomas comprises approximately 7 % - 8 % of all fi-
broadenoma subtypes and most often affect African American
adolescent girls. About 10 %-25 % of patients with juvenile
fibroadenomas have multiple or bilateral tumors at presenta-
tion. Multiple and bilateral tumors are commonly seen in
African American girls. Skin ulceration or prominent, dis-
tended superficial veins may develop due to rapid growth.5
Giant fibroadenoma may be adult type or juvenile type.6
Diagnostic criteria for juvenile fibroadenoma are (1) circum-
scribed and rarely multiple; (2) biphasic stromal and epithe-
lial process in which pericanalicular pattern is most common
and lacks leaf-like growth pattern in uniformly hyper cellular
stroma. Fibrotic areas may be present; (3) lack of atypical
features in stroma-like periductal increase in cellularity,
stromal overgrowth, cytological atypia, and mitotic rate
>3/hpf; (4) frequent epithelial and myoepithelial hyperplasia;
(5) most patients' age is 10-20 years with a mean age of 15
years. Juvenile fibroadenomas may be multiple.4
The exact etiology of giant juvenile fibroadenoma is not clear.
Fluctuation of estrogen hormonal may affect the enormous
growth of breast fibroadenoma.6 Other suggested etiology
may be an end-organ hypersensitivity to normal levels of
gonadal hormones.1
Giant juvenile fibroadenoma has to be differentiated from
cystosarcoma phyllodes which have a benign and malignant
form. It is important to differentiate the two pathologies
before operation as they have a different treatment approach
and different follow up. Benign low-grade phyllodes tumor
occurs in the older (> 40 years) age group and has no racial
predisposition. Generally, they present as a solitary mass
confined to unilateral breast, and bilateral involvement is
rarely seen. It is treated by wide excision with a margin of
normal tissue or mastectomy.6, 7 In children, both conditions
usually appear as well-circumscribed, hypoechoic masses at
sonography and show diffuse enhancement except for
non-enhancing septations at magnetic resonance imaging.
Although malignant tumors of the breast are rare in early age
group, two per cent of all primary malignant breast lesions
can occur in women under the age of 25 years.8 Giant juvenile
fibroadenoma should also be differentiated from a few other
conditions like virginal hypertrophy, breast lipoma, breast
hamartoma, breast abscess, huge breast cyst, adenocarcinoma,
and pseudoangiomatous stomal hyperplasia.
In juvenile breast hypertrophy affect adolescent female and
can result in rapid and distressing asymmetrical enlargement
of one or both breasts. Histological examination shows
abundant connective tissue and duct proliferation, frequently
with epithelial hyperplasia. It is treated by reduction mam-
moplasty.6, 9 Giant lipoma can cause soft, mobile mass in uni-
lateral breast. Histopathology reveals   encapsulated nodules
of mature adipose tissue.6, 9
Breast abscesses can cause sudden and rapid growth in the
breast with pain and redness. Histological examination usu-
ally shows focal collection of polymorphs with necrotic ma-
terial in the lobules. Hamartomas can also result in breast
enlargement and histologically reveals an admixture of ducts,
lobules, fibrous stroma, and adipose tissue in varying propor-
tions.
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Pseudoangiomatous stromal hyperplasia of breast reveals on
histopathologically a complex inter anastomosing spaces,
some of which have spindle-shaped stromal cells at their
margins simulating endothelial cells.6, 9
Giant juvenile fibroadenoma is a benign tumor, and total
excision of the lump with conservation of nipple and areola is
considered as the best treatment.6, 7, 9, 10 Sometimes it is diffi-
cult to diagnose by FNAC.11 In our patient, the diagnosis was
made clinically, substantiated by FNAC and confirmed by
histopathology.9 Fortunately, majority of these tumors can be
excised completely with preservation of the nipple and areo-
la, as was done in our patient. The biologic behavior of the
juvenile or cellular subtype of fibroadenomas is benign, but
metachronous lesions are not uncommon.12 Giant juvenile
fibroadenoma may recur after complete excision and the
chance of recurrence becomes less after third decade.13
Malignant changes in juvenile fibroadenoma female beast are
uncommon.  Breast malignancy is always treated with sur-
gery followed by radiation and chemotherapy. The lung is
one of the major dose-limiting organs for radiotherapy within
the thorax. Therefore, the total dose that can safely be deliv-
ered to patients with malignant tumors like carcinoma breast
has to be controled because of the risk of radiation pneu-
monitis (developing 1 to 6 months after treatment) and radi-
ation fibrosis (developing from 6 months onward). Chemo-
therapy (regardless of the type of drug) primarily affected the
diffusion capacity. Various studies have  analyzed whether
and how much the course in pulmonary function changes
over time, forced vital capacity [FVC], ratio of forced expir-
atory volume in 1second [FEV1/FVC ratio] varied between
the different treatment regimens and whether recovery of
early pulmonary damage occurred or not. In general, when
chemotherapy and radiotherapy are combined, two different
effects may occur as an interaction between both modalities,
resulting in an enhancement of radiation-induced damage or
an additional effect.14,15
Conclusion
The diagnosis and management of large breast tumors in the
pre-pubertal age group is challenging for pathologist and
surgeon. In the majority of the cases, these tumors are be-
nign and should be treated with breast sparing surgery.
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